Patrizia Nanni


Affiliation: University of Bologna
Country: Italy


  1. De Giovanni C, Landuzzi L, Palladini A, Ianzano M, Nicoletti G, Ruzzi F, et al. Cancer Vaccines Co-Targeting HER2/Neu and IGF1R. Cancers (Basel). 2019;11: pubmed publisher
    ..Cell vaccines co-targeting HER2/neu and IGF1R elicited low levels of specific antibodies that slightly delayed onset of HER2/neu-driven, IGF1R-dependent tumors. ..
  2. Croci S, Nanni P, Palladini A, Nicoletti G, Grosso V, Benegiamo G, et al. Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis. Breast Cancer Res. 2015;17:70 pubmed publisher
  3. Riccardo F, Arigoni M, Buson G, Zago E, Iezzi M, Longo D, et al. Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers. BMC Genomics. 2014;15 Suppl 3:S1 pubmed publisher
    ..Our study provided a complete transcription overview of the K-ras(LA1)/p53(R172H?g) mouse NSCLC model. This approach allowed the detection of ADORA3 as a potential target for antibody-based therapy in p53 mutated tumors. ..
  4. Pennisi M, Pappalardo F, Palladini A, Nicoletti G, Nanni P, Lollini P, et al. Modeling the competition between lung metastases and the immune system using agents. BMC Bioinformatics. 2010;11 Suppl 7:S13 pubmed publisher
    ..These results can be then used and verified in future "in vivo" experiments, and their outcome can be used to further improve and refine the model. ..